Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2013-04-26
Summary
The purpose of this study is to compare the tendency of plasma concentration and clearance of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis and septic shock with another marker of early prognosis represented by 48 hours delta sofa.
Conditions
- Severe Sepsis
- Septic Shock
Sponsors & Collaborators
-
Hospital Sao Domingos
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-01-31
Countries
- Brazil
Study Locations
More Related Trials
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock
NCT01231672 ·Status: COMPLETED
-
Triage Score VS Quick-Sofa Score in Septic Patients in the Emergency Department
NCT04913246 ·Status: COMPLETED
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
CO2 Gap Changes Versus Inferior Vena Cava Collapsibility in Relation to Cardiac Index as a Prognostic Value in Septic Shock
NCT06119815 ·Status: RECRUITING ·Phase: NA
-
Sodium Status in Septic Patients and Its Relation to Prognosis an Hospital Stay
NCT04564508 ·Status: UNKNOWN
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Early Targeted Antibiotic Therapy in Patients With Sepsis
NCT05459389 ·Status: COMPLETED ·Phase: NA
-
Endotoxin in Gram-negative Septic Shock
NCT01602354 ·Status: UNKNOWN
-
Platelets to Lymphocytes Ratio in Sepsis
NCT05399225 ·Status: UNKNOWN
-
Impact of the Introduction of a Performance Improvement Program on the Initial Management of Sepsis and Septic Shock in Adults in the Emergency Department: a Before-and-after Study (IPA-SOS)
NCT06657625 ·Status: ENROLLING_BY_INVITATION
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in Obstetric Patients
NCT04621539 ·Status: COMPLETED
-
Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock
NCT05921825 ·Status: UNKNOWN
-
Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic Control
NCT01013662 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Extracorporeal Cytokine Removal in Patients With Septic Shock in an Adult Intensive Care Unit
NCT04231695 ·Status: UNKNOWN
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Physiologic Indicators for Prognosis in Abdominal Sepsis Study
NCT03408600 ·Status: COMPLETED
-
Procalcitonin Monitoring Sepsis Study
NCT01523717 ·Status: COMPLETED
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock
NCT05825118 ·Status: UNKNOWN